Asian Phytocuticals Public Company Limited, or APCO, has launched BIM AD, a new product for brain health care, building on its expertise in immunotherapy from mangosteen extract to expand its portfolio in the Brain Health segment and move into the preventive wellness market. Professor Dr. Pichet Wiriyachitra, Chief Executive Officer, said BIM AD was developed by combining knowledge of stem cells and immunotherapy innovation through the concept of stimulating stem cells involved in the body's tissue creation and repair processes, aiming to support brain health care and long-term internal organ recovery. The company plans to publish the research on this innovation in an international academic journal within October. For its marketing plan, the company will focus mainly on the domestic market, targeting consumers aged 40 and over, and will use the BIM Advisor model as a channel to expand its customer base alongside health care education. Professor Dr. Pichet said APCO is a leader in stem cell care and recovery using natural innovations, and he believes the launch of BIM AD will help expand its customer base in the Brain Health segment and drive sales growth in the second half of this year.
Asian Phytoceuticals Public Company LimitedAPCO launched BIM AD, a new brain-health product built on its stem-cell/immunotherapy innovation, expanding its portfolio into the Brain Health segment.
